Pharmacological venous thromboembolism prophylaxis in radical prostatectomy

Background and aim: Pulmonary thromboembolism is one of the most common causes of non-surgical death in patients following urological abdominopelvic surgery. Since the beginning of prophylaxis for venous thromboembolic disease, episodes of deep vein thrombosis and pulmonary thromboembolism have decr...

Full description

Autores:

Tipo de recurso:

Fecha de publicación:

2020

Institución:

Universidad del Rosario

Repositorio:

Repositorio EdocUR - U. Rosario

Idioma:

eng

OAI Identifier:

oai:repository.urosario.edu.co:10336/22574

Acceso en línea:

https://doi.org/10.1016/j.medcli.2019.04.023
https://repository.urosario.edu.co/handle/10336/22574

Palabra clave:

Anticoagulant agent
Low molecular weight heparin
Adult
Aged
Article
Bleeding
Body mass
Controlled study
Deep vein thrombosis
Device therapy
Disease risk assessment
Human
Incidence
Lung embolism
Major clinical study
Mobilization
Postoperative complication
Postoperative hemorrhage
Prognosis
Prostatectomy
Retrospective study
Risk reduction
Surgical risk
Thrombosis prevention
Venous thromboembolism
Clinical variability
Radical prostatectomy
Thromboembolic prophylaxis

Rights

License

Abierto (Texto Completo)